Published in Eur J Neurol on December 01, 2008
Facioscapulohumeral muscular dystrophy presenting with unusual phenotypes and atypical morphological features of vacuolar myopathy. J Neurol (2010) 0.89
Atypical onset in a series of 122 cases with FacioScapuloHumeral Muscular Dystrophy. Clin Neurol Neurosurg (2011) 0.86
Alternative splicing and muscular dystrophy. RNA Biol (2010) 0.83
Clinical expression of facioscapulohumeral muscular dystrophy in carriers of 1-3 D4Z4 reduced alleles: experience of the FSHD Italian National Registry. BMJ Open (2016) 0.80
Low penetrance in facioscapulohumeral muscular dystrophy type 1 with large pathological D4Z4 alleles: a cross-sectional multicenter study. Orphanet J Rare Dis (2015) 0.80
Facioscapulohumeral muscular dystrophy. Neurol Clin (2014) 0.80
Facioscapulohumeral Muscular Dystrophy: More Complex than it Appears. Curr Mol Med (2014) 0.79
High Frequency Hearing Loss and Hyperactivity in DUX4 Transgenic Mice. PLoS One (2016) 0.75
Facioscapulohumeral dystrophy in children: design of a prospective, observational study on natural history, predictors and clinical impact (iFocus FSHD). BMC Neurol (2016) 0.75
Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model. Nat Commun (2017) 0.75
Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients. Neurobiol Aging (2005) 4.88
Exercise intolerance due to mutations in the cytochrome b gene of mitochondrial DNA. N Engl J Med (1999) 3.76
Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet (1998) 2.72
Critical illness myopathy and neuropathy. Lancet (1996) 2.71
Congenital muscular dystrophies with defective glycosylation of dystroglycan: a population study. Neurology (2009) 2.33
APOE and Alzheimer disease: a major gene with semi-dominant inheritance. Mol Psychiatry (2011) 2.31
Reliability of the North Star Ambulatory Assessment in a multicentric setting. Neuromuscul Disord (2009) 2.13
Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophy. Neurology (2006) 2.11
Functional changes in Duchenne muscular dystrophy: a 12-month longitudinal cohort study. Neurology (2011) 2.06
Clinical and biochemical features of muscle dysfunction in subclinical hypothyroidism. J Clin Endocrinol Metab (1997) 2.04
Causative and susceptibility genes for Alzheimer's disease: a review. Brain Res Bull (2003) 1.76
Emergency treatment of allergic reactions to Hymenoptera stings. Clin Exp Allergy (1991) 1.76
Type 1 fiber abnormalities in skeletal muscle of patients with hypertrophic and dilated cardiomyopathy: evidence of subclinical myogenic myopathy. J Am Coll Cardiol (1989) 1.76
The role of muscle biopsy in investigating isolated muscle pain. Neurology (2007) 1.54
Monitoring of urinary excretion of modified nucleosides in cancer patients using a set of six monoclonal antibodies. Cancer Lett (1992) 1.46
Neonatal diabetes and DQB1 typing. Diabetes Care (1996) 1.43
Lipoid proteinosis: case report and review of the literature. Acta Otorhinolaryngol Ital (2006) 1.42
Tumor outgrowth in peripheral blood mononuclear cell-injected SCID mice is not associated with early Epstein-Barr virus reactivation. Leukemia (2003) 1.40
Chemicals and drugs as triggers of food-associated disorder. Ann Allergy (1988) 1.39
An atypical presentation of sporadic adult-onset centronuclear myopathy. Clin Neuropathol (2007) 1.39
[A mortality study of recipients of compensation for asbestosis in Italy (1980-1990)]. Med Lav (1997) 1.38
Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample. Clin Genet (2009) 1.35
Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2). Neuromuscul Disord (2003) 1.33
A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy. Ann Neurol (2000) 1.22
Genome-wide haplotype association study identifies the FRMD4A gene as a risk locus for Alzheimer's disease. Mol Psychiatry (2012) 1.20
Central nervous system involvement in Anderson-Fabry disease: a clinical and MRI retrospective study. J Neurol Neurosurg Psychiatry (2008) 1.19
TARDBP (TDP-43) sequence analysis in patients with familial and sporadic ALS: identification of two novel mutations. Eur J Neurol (2009) 1.18
Maternally inherited hearing loss in a large kindred with a novel T7511C mutation in the mitochondrial DNA tRNA(Ser(UCN)) gene. Neurology (1999) 1.16
McArdle disease: a clinical review. J Neurol Neurosurg Psychiatry (2010) 1.16
In vivo regulation of oxidative phosphorylation in cells harboring a stop-codon mutation in mitochondrial DNA-encoded cytochrome c oxidase subunit I. J Biol Chem (2001) 1.16
Lysis protein S of phage lambda functions in Saccharomyces cerevisiae. J Bacteriol (1990) 1.15
Long-term survival in Stuve-Wiedemann syndrome: a neuro-myo-skeletal disorder with manifestations of dysautonomia. Am J Med Genet A (2003) 1.15
EFNS guidelines on the diagnostic approach to pauci- or asymptomatic hyperCKemia. Eur J Neurol (2010) 1.13
Observational clinical study in juvenile-adult glycogenosis type 2 patients undergoing enzyme replacement therapy for up to 4 years. J Neurol (2011) 1.11
Myophosphorylase deficiency (glycogenosis type V; McArdle disease). Curr Mol Med (2002) 1.11
Molecular diagnosis in LGMD2A: mutation analysis or protein testing? Hum Mutat (2004) 1.10
Familial multiple symmetric lipomatosis associated with the A8344G mutation of mitochondrial DNA. Neurology (1998) 1.09
A new mutation in the mitochondrial tRNA(Ala) gene in a patient with ophthalmoplegia and dysphagia. Neuromuscul Disord (2001) 1.09
Phenotypic manifestations associated with CAG-repeat expansion in the androgen receptor gene in male patients and heterozygous females: a clinical and molecular study of 30 families. Neuromuscul Disord (2000) 1.09
SPG3A: An additional family carrying a new atlastin mutation. Neurology (2002) 1.07
Pontocerebellar hypoplasia: clinical, pathologic, and genetic studies. Neurology (2010) 1.07
The oral allergy syndrome. Ann Allergy (1988) 1.05
Unusually high incidence of malignant pleural mesothelioma in a town of eastern Sicily: an epidemiological and environmental study. Arch Environ Health (2000) 1.05
Psychiatric comorbidity in a population of outpatients affected by tinnitus. Int J Audiol (2003) 1.03
Gadolinium-enhanced MR imaging in the differential diagnosis of placenta accreta and placenta percreta. Radiology (2000) 1.02
Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A quantitative volumetric, diffusion and proton spectroscopy MR study. Brain (2004) 1.02
Astrocyte-neuron interactions in neurological disorders. J Biol Phys (2009) 1.01
Reliability of the Hammersmith functional motor scale for spinal muscular atrophy in a multicentric study. Neuromuscul Disord (2006) 1.01
A nonsense mutation (G15059A) in the cytochrome b gene in a patient with exercise intolerance and myoglobinuria. Ann Neurol (1999) 1.00
Missense mutation in the mtDNA cytochrome b gene in a patient with myopathy. Neurology (1998) 1.00
Risk of arrhythmia in type I myotonic dystrophy: the role of clinical and genetic variables. J Neurol Neurosurg Psychiatry (2009) 0.99
CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease. Brain Res Bull (2008) 0.99
Detection and quasispecies analysis of hepatitis C virus in the cerebrospinal fluid of infected patients. J Neurovirol (1999) 0.99
The spatial distribution of visual attention in hemineglect and extinction patients. Brain (1998) 0.98
Role of topical and nutritional supplement to modify the oxidative stress. Int J Cosmet Sci (2002) 0.98
Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology (2000) 0.98
Exercise intolerance due to a nonsense mutation in the mtDNA ND4 gene. Ann Neurol (1999) 0.97
From mild cognitive impairment to dementia: a prevalence study in a district of Tuscany, Italy. Acta Neurol Scand (2005) 0.96
Autosomal dominant external ophthalmoplegia and bipolar affective disorder associated with a mutation in the ANT1 gene. Neuromuscul Disord (2003) 0.95
Identification of novel WFS1 mutations in Italian children with Wolfram syndrome. Hum Mutat (2001) 0.94
Anatomical and clinical study of a case of subacute encephalomyelitis with hyperekplexia syndrome. Ital J Neurol Sci (1988) 0.93
Muscle MRI in TRPV4-related congenital distal SMA. Neurology (2012) 0.93
Long-term treatment with idebenone and riboflavin in a patient with MELAS. Neurol Sci (2000) 0.93
Clinical and electrophysiological reports in a case of early onset myotonia congenita (Thomsen's disease) successfully treated with mexiletine. Acta Paediatr (1992) 0.93
A novel mitochondrial tRNAPhe mutation causes MERRF syndrome. Neurology (2004) 0.92
Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first? Curr Alzheimer Res (2008) 0.92
Hypomyelination and congenital cataract: neuroimaging features of a novel inherited white matter disorder. AJNR Am J Neuroradiol (2007) 0.92
Coenzyme Q10 in neuromuscular and neurodegenerative disorders. Curr Drug Targets (2010) 0.91
Lack of association between mtDNA haplogroups and Alzheimer's disease in Tuscany. Neurol Sci (2007) 0.91
Low prevalence of TT virus in the cerebrospinal fluid of viremic patients with central nervous system disorders. J Med Virol (2001) 0.91
The genetics of ataxia: through the labyrinth of the Minotaur, looking for Ariadne's thread. J Neurol (2014) 0.91
Impaired auditory brainstem-evoked responses in insulin-dependent diabetic subjects. Diabetes (1984) 0.91
Progressive sensorineural hearing loss in childhood. Pediatr Neurol (1999) 0.91
Congenital muscular dystrophy with defective alpha-dystroglycan, cerebellar hypoplasia, and epilepsy. Neurology (2009) 0.90
Neuroprotective effects of tetracyclines: molecular targets, animal models and human disease. CNS Neurol Disord Drug Targets (2009) 0.90
Targeting mitochondrial dysfunction and neurodegeneration by means of coenzyme Q10 and its analogues. Curr Med Chem (2011) 0.89
Heterosexual and homosexual transmission of hepatitis C virus: relation with hepatitis B virus and human immunodeficiency virus type 1. Epidemiol Infect (1991) 0.89
Covalent linking of haptens, proteins and nucleic acids to a modified polystyrene support. J Immunol Methods (1993) 0.89
Allelic and phenotypic heterogeneity in 49 Italian patients with the muscle form of CPT-II deficiency. Clin Genet (2011) 0.89
Grass pollen immunotherapy: a single year double-blind, placebo-controlled study in patients with grass pollen-induced asthma and rhinitis. J Allergy Clin Immunol (1984) 0.89
Searching for the role and the most suitable biomarkers of oxidative stress in Alzheimer's disease and in other neurodegenerative diseases. Neurobiol Aging (2005) 0.89
Mitochondria, cognitive impairment, and Alzheimer's disease. Int J Alzheimers Dis (2009) 0.89
McArdle disease: molecular genetic update. Acta Myol (2007) 0.88
Charcot-Marie-Tooth disease type I and related demyelinating neuropathies: Mutation analysis in a large cohort of Italian families. Hum Mutat (2001) 0.88
Congenital muscular dystrophies with cognitive impairment. A population study. Neurology (2010) 0.88
Expanding the clinical spectrum of POMT1 phenotype. Neurology (2006) 0.88
The Hammersmith functional score correlates with the SMN2 copy number: a multicentric study. Neuromuscul Disord (2007) 0.88
Familial isolated hyperCKaemia associated with a new mutation in the caveolin-3 (CAV-3) gene. J Neurol Neurosurg Psychiatry (2002) 0.88
Phenotypic heterogeneity in two unrelated Danon patients associated with the same LAMP-2 gene mutation. Neuropediatrics (2005) 0.88
Minipolymyoclonus in congenital nemaline myopathy: a nonspecific clinical marker of neurogenic dysfunction. Brain Dev (1991) 0.88
Prognostic factors in mild dystrophinopathies. J Neurol Sci (1996) 0.88
Liver cirrhosis in an infant with Chanarin-Dorfman syndrome caused by a novel splice-site mutation in ABHD5. Acta Paediatr (2010) 0.88
Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy. Brain Pathol (2001) 0.88
The role of vascular factors in late-onset sporadic Alzheimer's disease. Genetic and molecular aspects. Curr Alzheimer Res (2009) 0.88
The clinical spectrum of sarcoglycanopathies. Neurology (1999) 0.88
Comparative analysis of visual and semi-quantitative assessment of striatal [123I]FP-CIT-SPET binding in Parkinson's disease. Neurol Sci (2006) 0.88
Allogeneic bone marrow transplantation for Pearson's syndrome. Bone Marrow Transplant (2007) 0.87